Skip to content

Clinical trials

Observational Hyperinsulinism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperinsulinism Phase: Observational Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20071
20081
20091
20121
20141
20172
20181
20231
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting5
Terminated2
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)3
University of Aarhus2
Ali Chappell1
Attikon Hospital1
Comune di Napoli1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Henry Ford Health System1
Insel Gruppe AG, University Hospital Bern1
MemorialCare Health System1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperinsulinism23
Insulin Resistance10
Cardiovascular Diseases8
Diabetes Mellitus, Type 27
Hypertension7
Metabolic Syndrome7
Obesity7
Heart Diseases6
Diabetes Mellitus4
Acanthosis Nigricans2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.